The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 02, 2014

Filed:

Aug. 14, 2008
Applicants:

Lothar Schwink, Frankfurt am Main, DE;

Siegfried Stengelin, Frankfurt am Main, DE;

Matthias Gossel, Frankfurt am Main, DE;

Gerhard Hessler, Frankfurt am Main, DE;

Torsten Haack, Frankfurt am Main, DE;

Petra Lennig, Frankfurt am Main, DE;

Inventors:

Lothar Schwink, Frankfurt am Main, DE;

Siegfried Stengelin, Frankfurt am Main, DE;

Matthias Gossel, Frankfurt am Main, DE;

Gerhard Hessler, Frankfurt am Main, DE;

Torsten Haack, Frankfurt am Main, DE;

Petra Lennig, Frankfurt am Main, DE;

Assignee:

Sanofi, Paris, FR;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/551 (2006.01); A61K 31/541 (2006.01); A61K 31/5377 (2006.01); A61K 31/496 (2006.01); A61K 31/4725 (2006.01); C07D 405/14 (2006.01); C07D 401/14 (2006.01); C07D 401/10 (2006.01); C07D 487/04 (2006.01); C07D 487/10 (2006.01); C07D 417/14 (2006.01); C07D 513/04 (2006.01); C07D 413/14 (2006.01); C07D 407/14 (2006.01); C07D 413/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4725 (2013.01); A61K 31/496 (2013.01); A61K 31/5377 (2013.01); A61K 31/541 (2013.01); A61K 31/551 (2013.01); C07D 405/14 (2013.01); C07D 401/14 (2013.01); C07D 401/10 (2013.01); C07D 487/04 (2013.01); C07D 487/10 (2013.01); C07D 417/14 (2013.01); C07D 513/04 (2013.01); C07D 413/04 (2013.01); C07D 407/14 (2013.01);
Abstract

The invention relates to azacyclyl-substituted aryldihydroisoquinolinones and their derivatives, and their physiologically tolerated salts and physiologically functional derivatives, their preparation, medicaments comprising at least one azacyclyl-substituted aryldihydroisoquinolinone of the invention or its derivative, and the use of the azacyclyl-substituted aryldihydroisoquinolinones of the invention and their derivatives as MCH antagonists.


Find Patent Forward Citations

Loading…